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Abstract
Intra- host single nucleotide variants (iSNVs) have been increasingly used in genomic epidemiology to increase phylogenetic 
resolution and reconstruct fine- scale outbreak dynamics. These analyses are preferably done on sequence data from direct 
clinical samples, but in many cases due to low viral loads, there might not be enough genetic material for deep sequencing and 
iSNV determination. Isolation of the virus from clinical samples with low- passage number increases viral load, but few studies 
have investigated how dengue virus (DENV) culture isolation from a clinical sample impacts the consensus sequence and the 
intra- host virus population frequencies. In this study, we investigate consensus and iSNV frequency differences between DENV 
sequenced directly from clinical samples and their corresponding low- passage isolates. Twenty five DENV1 and DENV2 posi-
tive sera and their corresponding viral isolates (T. splendens inoculation and C6/36 passage) were obtained from a prospective 
cohort study in the Philippines. These were sequenced on MiSeq with minimum nucleotide depth of coverage of 500×, and 
iSNVs were detected using LoFreq. For both DENV1 and DENV2, we found a maximum of one consensus nucleotide difference 
between clinical sample and isolate. Interestingly, we found that iSNVs with frequencies ≥5 % were often preserved between 
the samples, and that the number of iSNV positions, and sample diversity, at this frequency cutoff did not differ significantly 
between the sample pairs (clinical sample and isolate) in either DENV1 or DENV2 data. Our results show that low- passage 
DENV isolate consensus genomes are largely representative of their direct sample parental viruses, and that low- passage 
isolates often mirror high frequency within- host variants from direct samples.
INTRODUCTION
Dengue virus (DENV) is the etiologic agent of dengue fever 
(DF) as well as the more severe forms of illness, dengue 
haemorrhagic fever (DHF) and dengue shock syndrome 
(DSS), which cause significant health problems each year. 
Approximately 50–100 million symptomatic DENV infec-
tions occur each year, with the greatest burden in tropical and 
subtropical regions. DENV is an arbovirus, a mosquito- borne 
RNA virus commonly transmitted by Aedes mosquitoes. It 
belongs to the Flavivirus genus of the Flaviviridae family and 
has four serotypes, DENV1, 2, 3 and 4. DENV consists of a 
genome approximately 11 kb nucleotides (nt) in length. The 
genome encodes three structural proteins, nucleocapsid (C), 
precursor membrane (prM) and envelope (E), as well as seven 
nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, 
and NS5) [1, 2].
Viral genome sequence data, including that of DENV, have 
increasingly been used in epidemics and outbreaks to provide 
more precise reconstructions of transmission dynamics and 
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This approach of genomic epidemiology for DENV has played 
a crucial role in analyses of spatial and temporal outbreak 
dynamics, virus dispersal tracking, genotype- phenotype 
associations, vaccine effectiveness, vector adaptation and 
many others [3–5]. Generally, genomic epidemiology studies 
analyse DENV consensus genomes derived from each host. 
However, DENV and other RNA viruses exist within a host as 
a population of intra- host variants, not as a single consensus 
genome. Advanced next- generation sequencing (NGS) tech-
nology can now detect intra- host viral variants present at low 
frequencies within a sample. Increasingly, the importance of 
these intra- host single nucleotide variants (iSNVs), and the 
amount of diversity they create within a host, has been high-
lighted in recent studies. For instance, Ko et al. described the 
presence and emergence of DENV intra- host variants with 
differing selection advantages affecting epidemic severity, 
and Descloux et al. suggested a correlation of DENV within- 
host diversity with disease severity [6, 7]. iSNVs have also 
been used for more precise tracking of viral transmission 
and spread within outbreaks and epidemics, providing more 
granular information on transmission chains and possible 
hotspots of viral dissemination [8, 9].
NGS of within- host viral populations is preferably done 
directly on clinical samples, such as blood, serum, naso-
pharyngeal swabs or saliva, cerebro- spinal fluid and others. 
However, in many cases, clinical samples may have low viral 
loads, thus not providing enough genetic material for deep 
sequencing and complete genome reconstruction with high 
depth of coverage, requirements that are needed for analyses 
of low- frequency variants within a sample. This creates bias in 
some DENV genomic epidemiological investigations as low- 
viremic individuals are excluded from genomic analysis yet 
likely play a major role in DENV epidemic dynamics [5, 10].
An alternative approach is to isolate the virus from clinical 
samples in cell culture and passage it a low number of times 
(typically less than three passages) in order to amplify the 
virus thereby allowing an increase in sequencing depth 
of coverage. Generally, it is thought that isolation and 
low- passaging does not change the consensus sequence 
of the virus. For instance, Vasilakis et al. investigated 
how passaging affects the consensus sequence of DENV, 
and although they did not compare direct clinical sample 
sequence to the sequence of the passaged isolates, they 
showed that passaging of isolates many times (n=5 or n=10) 
results in change of the virus consensus sequence while 
low- passage number (n=2) does not [11]. They suggested 
that these changes are most probably not due to a passaging 
bottleneck, but rather adaptation to cells. Importantly, they 
also showed that fewer passaging- induced consensus muta-
tions are found in viruses passaged through C6/36 cells 
(Aedes albopictus vector) compared to passaging in human 
cell lines or vector- human alternating cell lines. Likewise, 
Chen et al. showed an increasing number of mutations in 
DENV consensus sequences with the increased number of 
isolate passages (n=20, 30) [12]. However, no studies to date 
have compared how the sequence of DENV virus from a 
direct clinical sample may change due to passaging.
In addition to the lack of knowledge on how DENV isola-
tion from a clinical sample impacts the consensus sequence, 
there is no information on how the intra- host virus popula-
tion may change with isolation and passaging. This infor-
mation is scarce for arboviruses in general. Stapleford et al. 
compared Chikungunya virus (CHIKV) iSNVs in isolate 
samples, with single passage in mammalian or vector cell 
lines, with iSNVs in viruses from direct clinical samples 
[13]. They found that the high- frequency iSNVs were main-
tained over passaging. However, they also noted a decrease 
in overall diversity, with more diversity maintained when 
passaging one time through mammalian cells rather than 
vector cells. No such studies have been performed on 
DENV.
Because of the importance of accurate DENV consensus 
genomic data from a range of dengue case viral loads, 
as well as accurate estimations of the intra- host popula-
tions and minor variants, we sought to compare DENV 
consensus sequences from direct clinical samples (sera) 
to low- passage isolates derived from the same samples. In 
addition, we compare iSNV (minor variant) frequencies 
in DENV sequencing both in direct samples and their 
corresponding isolate genomes. This provides informa-
tion on the possible consensus changes low- passaging of 
DENV from direct clinical samples might induce, as well 
as any changes in the frequency of intra- host population 
variants. Since low- passaged DENV isolates are frequently 
and increasingly used in investigations of DENV diversity 
and spread, this study provides important insight into the 
effect of passaging on the DENV genome sequence.
METHODS
Specimen collection and viral passaging
Eleven DENV1 culture- positive sera and their corre-
sponding isolates, and 14 DENV2 culture- positive sera and 
their corresponding isolates, were received from the Armed 
Forces Research Institute of Medical Sciences (AFRIMS). 
These specimens were collected between 2012 and 2015 
from a prospective cohort study of incident dengue illness 
set in Cebu, the Philippines (WRAIR no. 1844). The 
isolates had been passaged as follows: undiluted plasma/
serum (0.34 µl/mosquito) was inoculated in 10–20 Toxo-
rhynchitis splendens mosquitoes. Amplification of virus in 
mosquitoes was assessed by an immunofluorescence assay 
(IFA) assay on head squash preparations. The bodies of IFA- 
positive mosquitoes were macerated and inoculated onto 
C6/36 cells. Following one passage, the virus was serotyped, 
aliquoted and stored at −70 °C or below.
Virus sequencing
200 ul of each clinical specimen and corresponding cultured 
isolate was used for RNA extraction with QIAamp Viral 
RNA Mini Kit (Qiagen, MD, USA). Full DENV genomes 
were amplified via Access Array (AA) system (Fluidigm 
Corporation, CA, USA) using 48 pairs of in- house DENV 
serotype- specific primers and the SuperScript III One- Step 
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RT- PCR system with Platinum Taq High Fidelity poly-
merase (ThermoFisher Scientific, MA, USA), and 35 cycles, 
followed by cDNA purification using Agencourt AMPure 
XP beads (Beckman Coulter, CA, USA). The PCR products 
were analysed using High Sensitivity DNA D5000 tapes 
(Agilent Technologies, CA, USA) on the Agilent Tapesta-
tion 4200 System (Agilent Technologies) to check cDNA 
quality and quantity. The NGS libraries were prepared using 
QIAseq FX DNA Library kit (Qiagen) following the manu-
facturer’s instructions. Then, 50 ng per sample of amplified 
amplicon was used as input DNA for library preparation. 
The input DNA was fragmented for 15 min and amplified 
six cycles. The purified indexed libraries were quantified 
with Agilent Tapestation using DNA D5000 tapes (Agilent). 
Equal molar quantities of libraries were pooled based on 
the Tapestation data. Pooled libraries were denatured and 
diluted to a final loading concentration of 11.5pM and 
loaded onto the Miseq sequencing reagent cartridge from 
Miseq Reagent kit v3, 600 cycles, (illumina, CA, USA) for 
sequencing.
Virus genome assembly and variant calling
DENV reads from each sample were mapped to one of 
four references: one DENV1 reference (AB204803) and 
three DENV2 references (KU509277, KM279601 and 
KU517847), which were determined by first mapping 
the sequenced samples to a concatenated reference file 
containing numerous DENV1 and DENV2 genomes with 
location listed as Philippines and year 2012 to 2015 from 
GenBank. Using mapping output to support the best- 
fitting reference for each sample, the sequenced samples 
were mapped again individually to one of the four refer-
ences. For the mapping and analysis, we used an in- house 
pipeline, NGS_Mapper that includes the variant caller 
LoFreq [14, 15]. Briefly, the default setting of 5/95 was 
used for the NGS_Mapper calling of intra- host nucleotide 
variants, allowing for analyses of variant frequencies per 
nucleotide position down to 5 %. In addition, we performed 
a separate analysis of variants present in the population at 
a frequency 1 % or higher. The minimum nucleotide Phred 
score threshold was set to 30. This means that any site 
containing a variant nucleotide of quality score greater than 
30 and present at, or greater than, 5 or 1 % would be anno-
tated as an ambiguous position. In addition, the minimum 
depth of coverage to detect a variants was set to 500×. The 
consensus genomes were quality checked and manually 
curated using IGV and Geneious version R10, as well as 
each sample’s VCF file for statistical support [16–18]. This 
post- assembly cleaning process of the final consensus was 
implemented to ensure removal of any nucleotide variants 
present due to primer- induced error (variants only occur-
ring in the known primer regions and only found at the 
ends of the reads), certain types of sequencing error, and 
strand bias higher than what was observed in confident 
calls from each genome, respectively. In addition, minor 
nucleotide variants that were consistently present at either 
ends of the reads were manually removed from the analyses, 
as these have previously been shown to be spurious [19]. All 
genomes have been submitted to GenBank under accession 
numbers MT832032–MT832080. Shannon entropy was 








 , where 
fi is the observed frequency of an iSNV, and adjusting for 
genome length of 10 179 nucleotides for DENV1 and 10 176 
nucleotides for DENV2.
Table 1. Number of consensus differences and positions with iSNVs per DENV1 genome from direct samples and their corresponding isolates
Sample name iSNVs ≥5 % direct sample iSNVs ≥5 % isolate iSNVs ≥1 % direct sample iSNVs ≥1 % isolate Consensus differences*
AB204803_D1_1 0 0 3 5 0
AB204803_D1_2 3 4 8 9 0
AB204803_D1_3 8 3 41† 7 0
AB204803_D1_4 2 1 5 2 0
AB204803_D1_5 0 0 6 4 0
AB204803_D1_6 1 1 5 7 0
AB204803_D1_7 1 1 6 2 0
AB204803_D1_8 3 3 4 6 0
AB204803_D1_9 0 19† na na 0
AB204803_D1_10 1 0 2 5 1
AB204803_D1_11 1 na na na na
na, Not assembled.
*Not including iSNV positions.
†Outlier sample.
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RESULTS
Full genomes were obtained for all 11 DENV1 viruses derived 
from the direct clinical samples and for 10 of their corre-
sponding virus isolates (T. splendens inoculation followed 
by one C6/36 passage). Full genomes were obtained from 14 
DENV2 viruses derived from the direct clinical samples and 
from all of their corresponding virus isolates (T. splendens 
inoculation followed by one C6/36 passage). The overall depth 
of genome coverage for all obtained sequences was >500× 
throughout the genome, and positions with intra- host Single 
Nucleotide Variants (iSNVs) were scanned for. Variants 
present at a frequency of 5 % or higher, and 1 % or higher, 
were called based on criteria described in Methods.
DENV1 consensus and iSNVs in direct sample 
versus corresponding culture
Of 22 DENV1 samples (11 direct- culture pairs), one genome, 
from the AB204803_D1_11 cultured virus, was not assembled. 
All except one direct- culture pair had identical consensus 
genomes (Table 1). One genome, from the AB204803_D1_9 
cultured virus, contained an unusual number of iSNV positions 
already at 5 % level cutoff and was deemed an outlier, pointing 
to possible contamination of this sample (Table 1). Thus, nine 
DENV1 samples were used for DENV1 iSNV comparisons 
between viruses sequenced directly from clinical samples and 
their corresponding cultured isolates. For 5 % cutoff analyses, 
two of the samples did not have any iSNV positions in the 
genomes derived from either the direct sample or the cultured 
virus (Table 1). For genomes from direct samples, the average 
number of iSNV positions was 2.1 (range 0–8) per genome 
(Table 1). For genomes from their corresponding isolates, the 
average number of iSNV positions was 1.4 (range 0–4) per 
genome (Table 1) and it did not differ significantly from the 
number of iSNV positions in the direct samples (P >0.05, f- 
test). On the 1 % variant frequency cutoff level, one additional 
direct sample (AB204803_D1_3) was found to be an outlier 
containing 33 iSNV positions. However, since this sample was 
included in the 5 % analyses, we performed statistical analyses 
for the 1 % data both including and excluding this sample. 
Excluding this outlier, the average number of iSNV positions 
was 4.9 (range 2–8) for the direct samples and 5.0 (range 2–9) 
for their isolates, not differing statistically (P >0.05). Including 
Table 2. DENV1 iSNV CDS positions for ≥5 % data, and their variant frequencies for samples mapped to reference AB204803
Sample CDS nt position Direct genome nt [AA] Isolate genome nt [AA]
AB204803_D1_2 1206 G[V]95 % A[V]=5 % G[V]=94 % A[V]=6 %
1323 T[T]>95 %* T[T]=93 % C[T]=7 %
2134 G[V]=86 % A[M]=14 % G[V]=88 % A[M]=12 %
8829 C[V]=37 % T[V]=63 % C[V]=39 % T[V]=61 %
AB204803_D1_3 66 T[R]=6 %; C[R]=94 % T[R]>95 %
844 A[R]=72 %; C[R]=28 % A[R]>95 %
1806 G[V]=86 %; A[V]=14 % G[V]=93 %; A[V]=14 %
1809 A[Q]=88 %; G[Q]=12 % A[Q]=92 %; G[Q]=18 %
1962 G[K]=81 %; T[K]=19 % G[K]>95 %
2061 C[R]=76 %; T[R]=24 % C[R]>95 %
3016 C[L]=75 % T[L]=25 % C[L]=81 % T[L]=19 %
6761 G[R]=39 % A[K]=61 % A[K]>95 %
AB204803_D1_4 5442 G[E]=6 % C[D]=94 % C[D]=>95 %
8310 C[G]=95 % A[G]=5 % C[G]=95 % A[G]=5 %
AB204803_D1_6 8628 C[F]=19 % T[F]=81 % C[F]=18 % T[F]=82 %
AB204803_D1_7 1655 C[T]=60 % T[M]=40 % C[T]=60 % T[M]=40 %
AB204803_D1_8 3512 C[T]=29 % T[I]=71 % C[T]=19 % T[I]=81 %
6750 G[L]=51 % A[L]=49 % G[L]=42 % A[L]=58 %
9261 A[R]=89 % G[R]=11 % A[R]=88 % G[R]=12 %
AB204803_D1_10 3306 T[D]=14 %; C[D]=86 % C[D]>95 %
AA, amino acid; nt, nucleotide.
*Minor variants were present, albeit at a frequency <5 %.
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the outlier, the average number of iSNV positions was 8.9 
(range 1–41) for the direct samples, making the number of 
iSNVs significantly higher for the direct samples (P <0.05).
We compared the positions with iSNVs, and variant frequen-
cies within those positions, between the genomes from DENV 
1 direct samples and their corresponding cultures, at both 5 
and 1 % variant frequency cutoffs. For the variant frequency 
cutoff of 5 %, we found that many iSNV positions overlapped 
between the direct sample and isolate viral populations 
(Table 2). Out of a total of 19 positions with iSNVs in the 
clinical DENV1 samples, 12 were also present in their isolates. 
Isolate samples had a total of 13 iSNV positions of which 12 
were also found in the clinical samples. (Table 2). In eight 
of the positions, a minor variant present at the frequency of 
≥5 % was found exclusively in either the direct sample or the 
isolate genome. Interestingly, some of these positions were 
confirmed to actually contain the corresponding variants, 
albeit at frequencies <5 % (Table S1, available in the online 
version of this article). The iSNV position overlap between 
direct sample and its isolate was less frequent for variants 
occurring at a frequency 1–5 % (Table S1).
Shannon entropy was calculated to measure the amount of 
diversity within each sample. The entropy did not significantly 
differ between direct samples and isolates at 5 % frequency 
cutoff (P >0.05)(Fig. S1). At 1 % frequency cutoff, the Shannon 
entropy was significantly higher for the direct samples 
(P=0.01), however, when the AB204803_D1_3 outlier was 
removed from the calculation, the Shannon entropy was not 
different between direct samples and their isolates (P >0.05) 
(Fig. S1).
DENV2 consensus and iSNVs in direct sample 
versus corresponding culture
Of 28 DENV2 samples (14 direct- culture pairs), all genomes 
were available for consensus and iSNV comparisons between 
clinical samples and their corresponding cultured viruses. 
There were 0–1 consensus genome differences found between 
the sample pairs (Table  3). For the 5 % variant frequency 
cutoff level, the average number of iSNV positions was 3.5 
(range 1–10) for direct samples. For genomes from their 
corresponding isolates, the average number of iSNV posi-
tions was 2.8 (range 0–6) per genome (Table 3). The number 
of iSNV positions did not differ significantly between direct 
samples and their isolates (P >0.05, f- test). On the 1 % 
variant frequency cutoff level, one additional direct sample 
(KM279601_D2_1) was found to be outlier containing 81 
iSNV positions. However, since this sample was included in 
the 5 % analyses, we performed statistical analyses for the 1 % 
data both including and excluding this sample. Excluding this 
outlier, the average number of iSNV positions was 15.5 (range 
2–42) for the direct samples and 4.2 (range 0–9) for their 
isolates, differing statistically (P <0.05). Including the outlier, 
the average number of iSNV positions was 20.1 (range 2–81) 
for the direct samples and 4.6 (range 1–9) for the isolates, also 
significantly different (P <0.05).
We compared the positions with iSNVs, and variant 
frequencies within those positions, at both 5 and 1% variant 
frequency cutoffs, for the genomes from DENV2 direct 
samples and their corresponding cultures (Tables 4, S2 and 
S3). For 5 % cutoff, 24 of 49 direct sample iSNV positions were 
also found in the isolates, and 24 of 39 isolate iSNV positions 
Table 3. Number of consensus differences and positions with iSNVs per DENV2 genome from direct samples and their corresponding isolates
Sample name iSNVs ≥5 % direct sample iSNVs ≥5 % isolate iSNVs ≥1 % direct sample iSNVs ≥1 % isolate Consensus differences*
KU509277_D2_1 3 3 5 3 0
KU509277_D2_2 3 3 6 6 0
KU509277_D2_3 2 2 33 3 0
KU517847_D2_1 5 3 17 7 0
KM279601_D2_1 10 6 81† 9 1
KM279601_D2_2 5 2 42 2 1
KM279601_D2_3 3 1 12 1 1
KM279601_D2_4 5 3 15 9 1
KM279601_D2_5 4 5 26 6 1
KM279601_D2_6 1 3 3 3 0
KM279601_D2_7 1 0 22 1 0
KM279601_D2_8 2 2 2 2 0
KM279601_D2_9 4 4 9 6 0
KM279601_D2_10 1 2 9 6 1
*Not including iSNV positions.
†Outlier sample.
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were also confirmed in the direct samples. As for DENV1, we 
observed DENV2 positions with a minor variant present at 
the frequency of ≥5 % found exclusively in either the direct 
sample or the isolate genome, however, some of these posi-
tions did have variants below 5 % frequency.
At 5 % level, there were no significant differences between 
DENV1 and DENV2 in the number of iSNV positions per 
genome in either direct or isolate samples (P >0.05). Simi-
larly to the results for DENV1, the iSNV position overlap 
between direct sample and its isolate was less frequent for 
DENV2 variants occurring at a frequency 1–5 % (Table S3). 
Shannon entropy was calculated to measure the amount of 
diversity within each sample. The entropy did not significantly 
differ between direct samples and isolates (including the 
KM279601_D2_1 outlier) at 5 % frequency cutoff, but was 
significant at the 1 % frequency cutoff (Fig. S2).
DISCUSSION
Genomic epidemiology is increasingly being used in dengue 
and other viral outbreaks to provide complementary insights 
into viral transmission and epidemic dynamics [4, 20]. 
Such information can be used for more precise tracking 
of viral transmission and locating possible hotspots of 
viral dissemination. However, consensus genomes provide 
limited epidemiological inference, particularly when sampled 
from infected cases closely linked in space and time [5]. To 
circumvent this problem and increase resolution, iSNVs have 
recently been used for more precise reconstructions of virus 
transmission chains [6–9]. For such studies, sequencing of 
viral genomes from clinical samples is ideal, however, the 
amount of genetic material may not be sufficient to achieve 
depth that is required for iSNV identification and analysis. 
Therefore, viruses from clinical samples may be amplified 
in cell culture, to achieve sufficient nucleic acid yields for 
primary analysis, as well as to preserve the virus for addi-
tional studies. Often, research reviews highlight sequencing of 
isolates as a limitation to direct sequencing of clinical samples, 
despite a relative absence of data showing passaged viruses 
having a different consensus sequence to its clinical parent. 
In this study we aimed to investigate whether low- passaging 
can change DENV genome consensus sequence, or the minor 
variant admixture, compared to a direct clinical specimen.
We compared virus from direct clinical samples and their 
corresponding cultured viruses for both DENV1 and DENV2, 
and found that there were no significant differences in the 
number of iSNV positions, or in the Shannon entropy, 
between the sample pairs (direct and isolate) when looking 
at variants present at 5 % or higher. This diversity preservation 
was also true when variant frequency cutoff was 1 % upon 
removal of outlier sample for DENV1, but not for DENV2. 
This suggests there was no increase or decrease in ≥5 % iSNV 
diversity following amplification of DENV through T. splen-
dens inoculation and one C6/36 passage, however, the isolate 
diversity did decrease for DENV2 when including variants at 
frequencies 1–5 %. These results are mainly in concordance 
with a previous study showing that the amount of dengue 
Table 4. DENV2 iSNV CDS positions and their variant frequencies, for ≥5 % data, for samples mapped to references KU509277 or KU517847
Sample CDS nt position Direct genome Isolate genome
KU509277_D2_1 2995 T[T]=5 %; C[T]=95 % C[T]>95 %
4056 T[A]=72 % C[A]=28 % T[A]=72 % C[A]=28 %
8085 T[A]=72 % C[A]=28 % T[A]=76 % C[A]=24 %
8308 A[K]>95 % G[K]=5 %; A[K]=95 %
KU509277_D2_2 1014 G[K]=72 % A[K]=28 % G[K]=86 % A[K]=14 %
2338 G[V]=91 % A[I]=10 % G[V]=93 % A[I]=7 %
4374 A[S]=91 % G[S]=9 % A[S]=94 % G[S]=6 %
KU509277_D2_3 1059 C[R]=>95 %* C[R]=94 % A[R]=6 %
1098 G[Q]=95 % A[Q]=5 % G[Q]=>95 %
8642 C[T]=84 % T[I]=16 % C[T]=82 % T[I]=18 %
KU517847_D2_1 512 A[N]=5 %; G[D]=95 % A[N]=5 %; G[D]=95 %
4617 G[R]=6 %; A[R]=94 % G[R]=5 %; A[R]=95 %
4959 T[I]=15 % A[I]=85 % T[I]=12 % A[I]=88 %
6128 G[R]=6 %; A[K]=94 % A[K]>95 %*
7591 C[L]=6 %; T[L]=94 % T[L]>95 %
nt, nucleotide; AA, amino acid.
*Minor variants were present, albeit at a frequency <5 %.
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intra- host diversity generally does not change when the virus 
is transmitted from human to mosquito [21]. Also in concord-
ance with previous human–mosquito transmission studies, 
we found that DENV iSNVs occurring at higher frequen-
cies (≥5 %) were often preserved after mosquito and C6/36 
culture passage [13, 21], although instances with iSNVs that 
were exclusive to either direct samples or cultured samples 
were observed. This was more pronounced when looking 
at variants present at lower frequencies (1 –5 %), suggesting 
that like in human–mosquito transmission, virus isolation 
may result in removal of low- frequency variants, followed 
by eventual restoration of diversity upon virus replication in 
culture, albeit with a different low- frequency iSNV repertoire. 
The lower diversity at 1 % cutoff in DENV2 isolate samples 
might mirror this purge of low- frequency minor variants 
from direct samples, where the iSNV repertoire had not been 
restored yet. The discrepant results between DENV1 and 
DENV2 diversity at 1 % variant frequency cutoff may be due 
to differences between the two serotypes, or may be that the 
threshold for low- frequency iSNV restoration is somewhere 
between 1–2 passages. This becomes important to consider in 
studies utilizing within- host variation for more precise trans-
mission inferences. However, we show that higher frequency 
iSNVs (≥5 %) were often preserved, and if these are found in 
low- passage isolates from epidemiologically linked cases, they 
may represent true instances of minor variant transmission.
We found none to very few (up to one per genome) consensus 
sequence changes between direct sample and isolate viruses. 
Consensus conservation has also been observed in human–
mosquito transmission studies, although it has been suggested 
that genome changes might occur and also differ depending 
on the mosquito species [21, 22]. A single nucleotide differ-
ence would not have a great impact on phylogenetic recon-
structions of DENV full genomes for molecular epidemiology 
studies, and our study shows that low virus passage may be 
used for phylogenetic inferences when not enough viral mate-
rial is available in clinical samples. However, a single (nonsyn-
onymous) nucleotide difference might have epidemiological 
importance in other contexts, such as in arbovirus adapta-
tion to the vector [23, 24]. In this study, the viruses were not 
passaged more than once, and a low- passage approach is 
commonly used for virus amplification for genomic surveil-
lance studies [3, 11]. Further studies can be performed to 
investigate the impact of increasing number of passages on 
DENV consensus sequence and maintenance of high- and 
low- frequency variants. In addition, further analyses on other 
DENV serotypes (DENV3 and DENV4) are needed, as well 
as confirmation of our results using other in vitro passage 
protocols and approaches that more thoroughly account for 
PCR, sequencing and basecalling algorithm errors.
In conclusion, we show that limited culture passaging had 
minimal effect on the consensus sequence of DENV from 
direct clinical samples, and that iSNV frequencies at ≥5 % 
were often maintained during passage. These data provide 
more confidence in using virus isolates as an alternative 
approach to deep sequence DENV intra- host viral popula-
tions, and mitigate epidemiological sampling limitations 
previously constrained by dengue case viral load. Our results 
serve as an important technical reference for DENV genomic 
epidemiology, virus dispersal tracking and vaccine effective-
ness studies.
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